Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...

After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

Ozempic breasts refer to changes in breast size or shape due to weight loss from GLP-1 drugs. Here’s how and why this side ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

In our country, 4 out of 10 adults are overweight, and slightly more than 1 in 10 live with a condition of obesity, a chronic ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...